Skip to main content
. 2017 Jul;153(1):178–190.e10. doi: 10.1053/j.gastro.2017.03.053

Supplementary Figure 4.

Supplementary Figure 4

EGFR signaling in myeloid cells promotes ApcMin-driven CRC development via STAT3 activation in tumor cells. (A) IHC staining for pSTAT3 and survivin in the ApcMin/+ model, arrowheads depict pSTAT3+ and survivin+ nuclei in tumor cells, respectively. Scale bars 50 μm. (B) pSTAT3 index was defined by dividing the number of pSTAT3+ tumor cells by the tumor area in ApcMin/+ mice (13–25 tumors from 3–4 different mice were counted). (C) Survivin index was defined by dividing the number of survivin+ tumor cells by area of tumors in ApcMin/+ mice (9–30 tumors from 3–5 different mice were counted). Data are mean ± SEM. ***P < .001, t test. #P < .05, ###P < .001, 1-way analysis of variance with Dunn’s posttest.